EUVIMEDEUVIMED entdecken
Leserbrief

When can weekly anti‐obesity peptides be used for monthly administration?

Daniel V Santi iD

Diabetes, Obesity and Metabolism · 2025-03 · 27 (3) · 1628-1629

DOI: 10.1111/dom.16134 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 20.12.2024. Verfasst von Daniel V Santi. Beteiligte Einrichtung: ProLynx, San Francisco, California, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.16134. Data is available to all.

Autor:innen und Institutionen

  • ProLynx, San Francisco, California, USA.
  • Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, USA.

ORCID-Profile: Daniel V Santi

Zitieren

APA

Santi, D. V. (2025). When can weekly anti‐obesity peptides be used for monthly administration?. Diabetes, Obesity and Metabolism, 27(3), 1628-1629. https://doi.org/10.1111/dom.16134

Vancouver

Santi DV. When can weekly anti‐obesity peptides be used for monthly administration?. Diabetes, Obesity and Metabolism. 2025;27(3):1628-1629. doi:10.1111/dom.16134

BibTeX
@article{Santi2025,
  author = {Santi, Daniel V},
  title = {When can weekly anti‐obesity peptides be used for monthly administration?},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  volume = {27},
  number = {3},
  pages = {1628--1629},
  doi = {10.1111/dom.16134}
}
Kostenlos starten →